Dimensional Fund Advisors LP Solid Biosciences Inc. Transaction History

Dimensional Fund Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $6,597 - $19,025	-15,343 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.74 - $1.79 $35,605 - $86,125	-48,115 Reduced 75.82%	15,343 $18,000
Q2 2021 Aug 12, 2021	SELL	$3.49 - $5.51 $40,040 - $63,216	-11,473 Reduced 15.31%	63,458 $232,000
Q4 2020 Feb 25, 2021	BUY	$3.08 - $7.79 $230,787 - $583,712	74,931 New	74,931 $568,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $22.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.